Monaghan Medical Is Focused on Protecting Caregivers while Providing Quality Therapy for Patients
PLATTSBURGH, NY (February 23, 2021) – Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy.
Nebulizer therapy is …
PLATTSBURGH, NY (November 24, 2020)—Monaghan Medical Corporation (Monaghan Medical) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the sixth consecutive year. The award is presented annually by the AARC based on ballots cast by respiratory …
Melbourne, Australia – 24 November 2020: Adherium Limited (ASX:ADR), a leader in digital inhaled device adherence, remote monitoring and data management solutions, is pleased to announce agreement of terms with leading respiratory company Monaghan Medical Corporation (Monaghan) to support the …
New headquarters building doubles the operational size and is designed to place workers’ safety first during the COVID-19 pandemic
PLATTSBURGH, NY (November 5, 2020) – Monaghan Medical Corporation (MMC) today announced the opening of a new 65,000-square-foot facility that doubles …
PLATTSBURGH, NY – 29 April 2020: Monaghan Medical Corporation today announced it has signed a letter of intent to enter into a sales agreement with Adherium Limited (ASX:ADR), a provider of digital health solutions for remote monitoring and data management. …
PLATTSBURGH, NY (January 7, 2020) – Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika® oscillatory positive expiratory pressure (OPEP) …
Award recognizes MMC’s outstanding respiratory products and services, and commitment to excellence.
PLATTSBURGH, NY (November 12, 2019)—Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year. The award was …
PLATTSBURGH, NY (June 5, 2019) – Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue their mission to ensure device quality for patients. Close to …
PLATTSBURGH, N.Y., Jan. 31, 2018 — A recent article in Pulmonary Pharmacology and Physiology1 provides in vitro evidence that the AEROCHAMBER …
Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary Therapy, indicates significant reductions in costs when using the AEROBIKA® oscillating positive expiratory pressure (OPEP) device in the postoperative care setting.1 …
SYRACUSE, NY, 21 February, 2017 – Monaghan Medical Corporation (MMC) today announced the publication of a study in Pulmonary Therapy showing treatment with the Aerobika® device can significantly reduce the recurrence of exacerbations of COPD in the crucial 30-day …
SYRACUSE, NY, January 12, 2017 – Monaghan Medical Corporation (MMC) today announced that the findings of a study published in the most recent issue of Academic Radiology shows that patients with non-cystic fibrosis (CF) bronchiectasis responded favorably to airway maintenance …
SYRACUSE, NY, October 27, 2016 – Monaghan Medical Corporation (MMC) today announced that a new study presented to the American College of Chest Physicians (CHEST) shows MMC’s Aerobika® device …